Skip to Main Content
Table 1

Characteristics of study participants

CharacteristicPlacebo (N = 53)Pulmicort (N = 53)
Age, y   
 Median 58 55 
 Range 42–74 44–74 
Sex, no. (%)   
 Male 39 (74) 38 (72) 
 Female 14 (26) 15 (28) 
Smoking history, pack-years   
 Median 52 44 
 Range 30–93 27–115 
Smoking status, no. (%)   
 Current smoker 44 (83) 39 (74) 
 Former smoker 9 (17) 14 (26)* 
Highest grade of dysplasia in baseline biopsy samples, no. (%) 41 (77) 46 (87) 
 Mild 12 (23) 7 (13) 
 Moderate/Severe 41 (77) 39 (74) 
≥2 sites of dysplasia, no. (%)  
10-year lung cancer risk (%) (1–11) (1–11) 
CharacteristicPlacebo (N = 53)Pulmicort (N = 53)
Age, y   
 Median 58 55 
 Range 42–74 44–74 
Sex, no. (%)   
 Male 39 (74) 38 (72) 
 Female 14 (26) 15 (28) 
Smoking history, pack-years   
 Median 52 44 
 Range 30–93 27–115 
Smoking status, no. (%)   
 Current smoker 44 (83) 39 (74) 
 Former smoker 9 (17) 14 (26)* 
Highest grade of dysplasia in baseline biopsy samples, no. (%) 41 (77) 46 (87) 
 Mild 12 (23) 7 (13) 
 Moderate/Severe 41 (77) 39 (74) 
≥2 sites of dysplasia, no. (%)  
10-year lung cancer risk (%) (1–11) (1–11) 
*

The number of former smokers in the placebo group was not statistically significantly different from the number of former smokers in the Pulmicort group (P = 0.25; χ2 test).

Risk assessment using algorithm reported by Bach et al. (27) assuming the current smokers stopped smoking at enrollment.

Close Modal

or Create an Account

Close Modal
Close Modal